[Sinonasal cancers].

Sinonasal cancers. Sinonasal cancers (SNC) belong to the spectrum of rare tumors, with respect to other tumors of the head and neck and intrinsically by the multiple histological entities that they cover. It is important to raise awareness among physicians about the diagnostic and therapeutic elements of SNC, as well as their functional consequences, so that these patients are better diagnosed and monitored during and following specific oncological treatment. We also shed light on the various histological entities and new therapeutic options, in particular endoscopic surgery, conformational radiotherapy and systemic treatments. Finally, we underline the importance of the REFCOR network of expertise, which makes it possible to offer optimal management of these rare tumors, and of the CORASSO association, which provides patients a major additional extra-medical support.
Competing Interests: B. Verillaud déclare participer à des interventions ponctuelles pour Sanofi Genzyme et Amplifon.F.-R. Ferrand, J. Thariat et N. Le Clerc n’ont pas transmis de déclaration d’intérêts.